Quest Diagnostics Inc (NYSE:DGX) may be encountering what you might call a post-earnings digestion dance. Initially, DGX stock jumped higher, perhaps due to the algorithms and retail traders responding in unison to the better-than-expected results for the second quarter. But the next day, the security slipped, possibly as fund managers more carefully digested the underlying conference call and guidance. Now, DGX is moving steadily higher again.
You got to let the market speak for itself, which will tell you where it may head next. Rather than mere opinions, though, we can use science to decipher clues regarding DGX stock.
